Cargando…
Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades
BACKGROUND: Recent therapeutic developments demand for an update of information on natural history, risk factors and prognosis of peritoneal carcinomatosis (PC) of colorectal origin. Therefore, prospective registry data should provide information about incidence, predictors and outcome. METHODS: Fro...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629432/ https://www.ncbi.nlm.nih.gov/pubmed/23511564 http://dx.doi.org/10.1038/bjc.2013.82 |
_version_ | 1782266581409071104 |
---|---|
author | Kerscher, A G Chua, T C Gasser, M Maeder, U Kunzmann, V Isbert, C Germer, C T Pelz, J O W |
author_facet | Kerscher, A G Chua, T C Gasser, M Maeder, U Kunzmann, V Isbert, C Germer, C T Pelz, J O W |
author_sort | Kerscher, A G |
collection | PubMed |
description | BACKGROUND: Recent therapeutic developments demand for an update of information on natural history, risk factors and prognosis of peritoneal carcinomatosis (PC) of colorectal origin. Therefore, prospective registry data should provide information about incidence, predictors and outcome. METHODS: From a prospectively expanded single-institutional database with 2406 consecutive patients with colorectal cancer (CRC), clinical, histological and survival data were analysed for independent risk factors and prognosis. Findings were then stratified to the era of treatment without chemotherapy, 5-Fluorouracil-only and contemporary systemic chemotherapy, respectively. RESULTS: Overall, 256 (10.6%) patients were diagnosed with PC thereof 141 (5.85%) with metachronous PC. Independent risk factors for the development of metachronous PC were age <62 years, N2-status, T4-status, location of the primary in the left colon or appendix. In the era of contemporary systemic chemotherapy, prognosis for PC improved only not-significantly (median survival of 17.9 months vs 7.03 months, P=0.054). CONCLUSION: Despite improvement in the overall outcome with prolonged median survival for the complete patient cohort with CRC, those patients with PC have not experienced the same benefit. In the era of contemporary systemic chemotherapy, progress in treatment resulted in only limited survival benefit. Thus, continuous efforts for further therapeutic advancements should be undertaken in these patients diagnosed with PC. |
format | Online Article Text |
id | pubmed-3629432 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-36294322014-04-16 Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades Kerscher, A G Chua, T C Gasser, M Maeder, U Kunzmann, V Isbert, C Germer, C T Pelz, J O W Br J Cancer Clinical Study BACKGROUND: Recent therapeutic developments demand for an update of information on natural history, risk factors and prognosis of peritoneal carcinomatosis (PC) of colorectal origin. Therefore, prospective registry data should provide information about incidence, predictors and outcome. METHODS: From a prospectively expanded single-institutional database with 2406 consecutive patients with colorectal cancer (CRC), clinical, histological and survival data were analysed for independent risk factors and prognosis. Findings were then stratified to the era of treatment without chemotherapy, 5-Fluorouracil-only and contemporary systemic chemotherapy, respectively. RESULTS: Overall, 256 (10.6%) patients were diagnosed with PC thereof 141 (5.85%) with metachronous PC. Independent risk factors for the development of metachronous PC were age <62 years, N2-status, T4-status, location of the primary in the left colon or appendix. In the era of contemporary systemic chemotherapy, prognosis for PC improved only not-significantly (median survival of 17.9 months vs 7.03 months, P=0.054). CONCLUSION: Despite improvement in the overall outcome with prolonged median survival for the complete patient cohort with CRC, those patients with PC have not experienced the same benefit. In the era of contemporary systemic chemotherapy, progress in treatment resulted in only limited survival benefit. Thus, continuous efforts for further therapeutic advancements should be undertaken in these patients diagnosed with PC. Nature Publishing Group 2013-04-16 2013-03-19 /pmc/articles/PMC3629432/ /pubmed/23511564 http://dx.doi.org/10.1038/bjc.2013.82 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Clinical Study Kerscher, A G Chua, T C Gasser, M Maeder, U Kunzmann, V Isbert, C Germer, C T Pelz, J O W Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades |
title | Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades |
title_full | Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades |
title_fullStr | Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades |
title_full_unstemmed | Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades |
title_short | Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades |
title_sort | impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629432/ https://www.ncbi.nlm.nih.gov/pubmed/23511564 http://dx.doi.org/10.1038/bjc.2013.82 |
work_keys_str_mv | AT kerscherag impactofperitonealcarcinomatosisinthediseasehistoryofcolorectalcancermanagementalongitudinalexperienceof2406patientsovertwodecades AT chuatc impactofperitonealcarcinomatosisinthediseasehistoryofcolorectalcancermanagementalongitudinalexperienceof2406patientsovertwodecades AT gasserm impactofperitonealcarcinomatosisinthediseasehistoryofcolorectalcancermanagementalongitudinalexperienceof2406patientsovertwodecades AT maederu impactofperitonealcarcinomatosisinthediseasehistoryofcolorectalcancermanagementalongitudinalexperienceof2406patientsovertwodecades AT kunzmannv impactofperitonealcarcinomatosisinthediseasehistoryofcolorectalcancermanagementalongitudinalexperienceof2406patientsovertwodecades AT isbertc impactofperitonealcarcinomatosisinthediseasehistoryofcolorectalcancermanagementalongitudinalexperienceof2406patientsovertwodecades AT germerct impactofperitonealcarcinomatosisinthediseasehistoryofcolorectalcancermanagementalongitudinalexperienceof2406patientsovertwodecades AT pelzjow impactofperitonealcarcinomatosisinthediseasehistoryofcolorectalcancermanagementalongitudinalexperienceof2406patientsovertwodecades |